臨床試験セントラルラボサービスの市場規模、シェア、動向分析レポート：フェーズ別、サービス別、適応症別、最終用途別、地域別、セグメント予測、2025年～2030年

臨床試験セントラルラボサービス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の臨床試験セントラルラボサービス市場規模は2030年までに69億7,000万米ドルに達し、2025年から2030年にかけてCAGR 9.8％で成長すると予測されています。

この市場を牽引しているのは、臨床試験の増加、バイオマーカーベースの検査に対する需要の高まり、規制要件の厳格化、分散型試験の採用拡大などです。さらに、AI主導の分析、自動化、デジタルラボ管理システムなどの技術的進歩により、効率性がさらに向上し、納期が短縮され、試験結果全体が改善されます。

医薬品開発プログラムの増加や研究開発への投資の増加により、市場は急速に拡大しています。製薬会社やバイオテクノロジー企業は、革新的な治療法を市場に投入するため、より多くの臨床試験を実施しており、専門的なラボ・サービスへの需要をさらに押し上げています。バイオマーカーに基づく検査、ゲノム解析、薬物動態学研究は臨床試験に不可欠なものとなりつつあり、高度なラボ能力を必要としています。規制当局は医薬品承認に厳格なガイドラインを課しており、コンプライアンス、データの正確性、標準化された検査手順を確保するために集中型ラボサービスが不可欠となっています。

さらに、分散型臨床試験やバーチャル臨床試験へのシフトは業界をさらに変革し、効率的なサンプル収集、リアルタイムのデータ統合、遠隔検査ソリューションの必要性を高めています。AI主導の分析、自動化、デジタルラボ管理システムなどの新技術は、業務効率を高め、試験スケジュールを加速します。さらに、製薬会社、CRO、セントラルラボプロバイダー間の戦略的提携は、ラボのネットワークを強化し、世界な検査能力を拡大します。個別化医療と精密治療への注目の高まりは、高品質なラボサービスへの需要を継続的に煽り、業界の著しい成長を加速させています。

市場の主要プレーヤーは、市場での地位を強化するために様々な戦略を採用しています。これには、戦略的パートナーシップ、M&A、世界な展開を強化するための検査室ネットワークの拡大などが含まれます。各社はまた、AI主導の分析、自動化、バイオマーカーに基づく検査などの先進技術に投資し、効率と精度を向上させています。例えば、2025年2月、LabConnectはSapio Sciencesとパートナーシップ契約を締結し、検査室情報管理システム（LIMS）を導入しました。この提携は、複雑な研究ワークフローをさらにデジタル化し、LabConnectの業務におけるサンプル追跡を合理化し、データ管理を強化することを目的としています。

臨床試験セントラルラボサービス市場レポートハイライト

• サービス別では、ゲノムおよび分子検査の進歩により、バイオマーカー検査サービスが市場を席巻。規制当局もバイオマーカーに基づく医薬品承認を奨励しており、市場拡大にさらに拍車をかけています。
• フェーズ別では、大量のサンプルと広範な検査要件により、フェーズIIIが2024年に最大の市場シェアを占めました。後期臨床試験の増加と規制当局の義務付けが、中央検査室サービスの需要をさらに押し上げています。
• 適応症別では、がん罹患率の上昇と新規治療法の臨床試験の増加により、2024年に冷凍が最大の市場シェアを占めました。個別化医療とバイオマーカーに基づく診断への注目の高まりが、専門的なラボ検査の需要を高めています。
• 最終用途別では、製薬・バイオ製薬企業が、その高い研究開発投資と広範な臨床試験パイプラインにより、2024年に最大の市場シェアを占めました。専門的検査、バイオマーカー分析、精密医療に対する需要の増加は、中央研究所への依存をさらに強めています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助市場展望
• 市場動向と展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 技術の進歩
  • AIとデジタル技術の統合
• 価格モデル分析
• 臨床試験件数分析、2024年
  • 地域別臨床試験総数（2024年）
  • 臨床試験の総数（フェーズ別）（2024年）
  • 臨床試験の総数（研究デザイン別）（2024年）
  • 主要治療領域別臨床試験総数（2024年）
• 業界分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 臨床試験セントラルラボサービス市場：サービス別推定・動向分析

• セグメントダッシュボード
• 臨床試験セントラルラボサービス市場：サービス変動分析
• 臨床試験セントラルラボサービス規模と動向分析（サービス別、2018～2030年）
• バイオマーカー検査サービス
• 微生物学サービス
• 解剖病理学/組織学
• 薬物動態/薬力学（PK/PD）
• ゲノムおよび分子検査
• サンプルの収集と処理
• 物流とサンプル管理
• データ管理とレポート
• その他

第5章 臨床試験セントラルラボサービス市場：フェーズ別推定・動向分析

• セグメントダッシュボード
• 臨床試験セントラルラボサービス市場：フェーズ変動分析
• 臨床試験セントラルラボサービス規模と動向分析（フェーズ別、2018～2030年）
• フェーズI
• フェーズII
• フェーズIII
• フェーズIV

第6章 臨床試験セントラルラボサービス市場：適応症別推定・動向分析

• セグメントダッシュボード
• 臨床試験セントラルラボサービス市場：適応症変動分析
• 臨床試験セントラルラボサービス規模と動向分析（適応症別、2018～2030年）
• 腫瘍学
• 心臓病学
• 神経学
• 感染症
• 免疫学と自己免疫疾患
• その他

第7章 臨床試験セントラルラボサービス市場：最終用途別推定・動向分析

• セグメントダッシュボード
• 臨床試験セントラルラボサービス市場：最終用途変動分析
• 臨床試験セントラルラボサービス規模と動向分析（最終用途別、2018～2030年）
• 製薬・バイオテクノロジー企業
• 受託研究機関
• その他

第8章 臨床試験セントラルラボサービス市場：地域別推定・動向分析

• 地域ダッシュボード
• 市場規模と予測および動向分析、2018年から2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 企業分類
• 企業市況分析、2024年
• 企業プロファイル
  • Labcorp
  • ICON plc
  • Eurofins Scientific
  • Thermo Fisher Scientific Inc.
  • Medpace
  • Q2 Solutions
  • Syneos Health
  • Charles River Laboratories
  • SGS
  • LabConnect

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 4 Global Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 5 Global Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 6 Global Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 7 Global Clinical Trial Central Laboratory Services Market, by Region, 2018 - 2030 (USD Million)
• Table 8 North America Clinical Trial Central Laboratory Services Market, by Country, 2018 - 2030 (USD Million)
• Table 9 North America Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 10 North America Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 11 North America Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 12 North America Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 13 U.S. Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 14 U.S. Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 15 U.S. Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 16 U.S. Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 17 Canada Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 18 Canada Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 19 Canada Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 20 Canada Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 21 Mexico Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 22 Mexico Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 23 Mexico Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 24 Mexico Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 25 Europe Clinical Trial Central Laboratory Services Market, by Country, 2018 - 2030 (USD Million)
• Table 26 Europe Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 27 Europe Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 28 Europe Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 29 Europe Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 30 UK Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 31 UK Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 32 UK Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 33 UK Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 34 Germany Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 35 Germany Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 36 Germany Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 37 Germany Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 38 France Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 39 France Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 40 France Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 41 France Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 42 Italy Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 43 Italy Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 44 Italy Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 45 Italy Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 46 Spain Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 47 Spain Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 48 Spain Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 49 Spain Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 50 Denmark Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 51 Denmark Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 52 Denmark Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 53 Denmark Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 54 Sweden Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 55 Sweden Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 56 Sweden Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 57 Sweden Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 58 Norway Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 59 Norway Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 60 Norway Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 61 Norway Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific Clinical Trial Central Laboratory Services Market, by Country, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 66 Asia Pacific Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 67 Japan Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 68 Japan Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 69 Japan Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 70 Japan Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 71 China Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 72 China Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 73 China Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 74 China Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 75 India Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 76 India Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 77 India Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 78 India Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 79 Australia Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 80 Australia Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 81 Australia Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 82 Australia Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 83 South Korea Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 84 South Korea Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 85 South Korea Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 86 South Korea Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 87 Thailand Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 88 Thailand Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 89 Thailand Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 90 Thailand Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 91 Latin America Clinical Trial Central Laboratory Services Market, by Country, 2018 - 2030 (USD Million)
• Table 92 Latin America Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 93 Latin America Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 94 Latin America Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 95 Latin America Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 96 Brazil Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 97 Brazil Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 98 Brazil Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 99 Brazil Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 100 Argentina Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 101 Argentina Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 102 Argentina Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 103 Argentina Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 104 MEA Clinical Trial Central Laboratory Services Market, by Country, 2018 - 2030 (USD Million)
• Table 105 MEA Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 106 MEA Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 107 MEA Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 108 South Africa Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 109 South Africa Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 110 South Africa Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 111 South Africa Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 112 Saudi Arabia Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 116 UAE Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 117 UAE Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 118 UAE Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 119 UAE Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
• Table 120 Kuwait Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
• Table 121 Kuwait Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
• Table 122 Kuwait Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
• Table 123 Kuwait Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Clinical Trial Central Laboratory Services Market Segmentation
• Fig. 7 Market Snapshot, 2024
• Fig. 8 Market Trends & Outlook
• Fig. 9 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 10 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Global Clinical Trial Central Laboratory Services Market: Service Key Takeaways
• Fig. 14 Global Clinical Trial Central Laboratory Services Market: Service Movement Analysis
• Fig. 15 Global Clinical Trial Central Laboratory Services Market, for Biomarker Testing Services, 2018 - 2030 (USD Million)
• Fig. 16 Global Clinical Trial Central Laboratory Services Market, for Microbiology Services, 2018 - 2030 (USD Million)
• Fig. 17 Global Clinical Trial Central Laboratory Services Market, for Anatomic Pathology/Histology, 2018 - 2030 (USD Million)
• Fig. 18 Global Clinical Trial Central Laboratory Services Market, for Pharmacokinetics/Pharmacodynamics (PK/PD), 2018 - 2030 (USD Million)
• Fig. 19 Global Clinical Trial Central Laboratory Services Market, for Genomic and Molecular Testing, 2018 - 2030 (USD Million)
• Fig. 20 Global Clinical Trial Central Laboratory Services Market, for Sample Collection and Processing, 2018 - 2030 (USD Million)
• Fig. 21 Global Clinical Trial Central Laboratory Services Market, for Monitoring & Visibility Solutions, 2018 - 2030 (USD Million)
• Fig. 22 Global Clinical Trial Central Laboratory Services Market, for Logistics & Sample Management, 2018 - 2030 (USD Million)
• Fig. 23 Global Clinical Trial Central Laboratory Services Market, for Data Management & Reporting, 2018 - 2030 (USD Million)
• Fig. 24 Global Clinical Trial Central Laboratory Services Market, for Others, 2018 - 2030 (USD Million)
• Fig. 25 Global Clinical Trial Central Laboratory Services Market: Phase Key Takeaways
• Fig. 26 Global Clinical Trial Central Laboratory Services Market: Phase Movement Analysis
• Fig. 27 Global Clinical Trial Central Laboratory Services Market, for Phase I, 2018 - 2030 (USD Million)
• Fig. 28 Global Clinical Trial Central Laboratory Services Market, for Phase II, 2018 - 2030 (USD Million)
• Fig. 29 Global Clinical Trial Central Laboratory Services Market, for Phase III, 2018 - 2030 (USD Million)
• Fig. 30 Global Clinical Trial Central Laboratory Services Market, for Phase IV, 2018 - 2030 (USD Million)
• Fig. 31 Global Clinical Trial Central Laboratory Services Market: Indication Key Takeaways
• Fig. 32 Global Clinical Trial Central Laboratory Services Market, Indication Movement Analysis
• Fig. 33 Global Clinical Trial Central Laboratory Services Market, for Oncology, 2018 - 2030 (USD Million)
• Fig. 34 Global Clinical Trial Central Laboratory Services Market, for Cardiology, 2018 - 2030 (USD Million)
• Fig. 35 Global Clinical Trial Central Laboratory Services Market, for Neurology, 2018 - 2030 (USD Million)
• Fig. 36 Global Clinical Trial Central Laboratory Services Market, for Infectious Diseases, 2018 - 2030 (USD Million)
• Fig. 37 Global Clinical Trial Central Laboratory Services Market, for Immunology & Autoimmune Diseases, 2018 - 2030 (USD Million)
• Fig. 38 Global Clinical Trial Central Laboratory Services Market, for Others, 2018 - 2030 (USD Million)
• Fig. 39 Global Clinical Trial Central Laboratory Services Market: End Use Key Takeaways
• Fig. 40 Global Clinical Trial Central Laboratory Services Market, End Use Movement Analysis
• Fig. 41 Global Clinical Trial Central Laboratory Services Market, for Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
• Fig. 42 Global Clinical Trial Central Laboratory Services Market, for Contract Research Organizations, 2018 - 2030 (USD Million)
• Fig. 43 Global Clinical Trial Central Laboratory Services Market, for Others, 2018 - 2030 (USD Million)
• Fig. 44 Regional Marketplace: Key Takeaways
• Fig. 45 Regional Outlook, 2024 & 2030
• Fig. 46 North America Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 47 U.S. Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 48 Canada Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 49 Mexico Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 50 Europe Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 51 Germany Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 52 UK Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 53 France Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 54 Italy Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 55 Spain Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 56 Denmark Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 57 Sweden Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 58 Norway Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 59 Asia Pacific Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 60 Japan Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 61 China Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 62 India Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 63 Australia Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 64 South Korea Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 65 Thailand Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 66 Latin America Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 67 Brazil Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 68 Argentina Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 69 Middle East and Africa Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 70 South Africa Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 71 Saudi Arabia Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 72 UAE Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
• Fig. 73 Kuwait Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)

Clinical Trial Central Laboratory Services Market Growth & Trends:

The global clinical trial central laboratory services market size is expected to reach USD 6.97 billion by 2030, growing at a CAGR of 9.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the increasing number of clinical trials, rising demand for biomarker-based testing, stringent regulatory requirements, and growing adoption of decentralized trials. Moreover, technological advancements such as AI-driven analytics, automation, and digital lab management systems further enhance efficiency, reduce turnaround times, and improve overall trial outcomes.

The market is expanding rapidly due to the increasing number of drug development programs and growing investments in research and development. Pharmaceutical and biotechnology companies are conducting more clinical trials to bring innovative therapies to market, further driving the demand for specialized laboratory services. Biomarker-based testing, genomic analysis, and pharmacokinetics studies are becoming essential for clinical trials, requiring advanced lab capabilities. Regulatory authorities are imposing stringent guidelines for drug approval, making centralized laboratory services critical for ensuring compliance, data accuracy, and standardized testing procedures.

Furthermore, the shift toward decentralized and virtual trials further transforms the industry, increasing the need for efficient sample collection, real-time data integration, and remote testing solutions. Emerging technologies such as AI-driven analytics, automation, and digital lab management systems enhance operational efficiency and accelerate trial timelines. Moreover, strategic collaborations between pharmaceutical companies, CROs, and central lab providers strengthen laboratory networks and expand global testing capabilities. The growing focus on personalized medicine and precision therapies continues to fuel demand for high-quality laboratory services, accelerating the industry's significant growth.

Key market players are adopting various strategies to strengthen their market position. These include strategic partnerships, mergers and acquisitions, and expanding laboratory networks to enhance global reach. Companies also invest in advanced technologies such as AI-driven analytics, automation, and biomarker-based testing to improve efficiency and accuracy. For instance, in February 2025, LabConnect entered into a partnership agreement with Sapio Sciences to implement a Laboratory Information Management System (LIMS). This collaboration aims to further digitally transform complex research workflows, streamlining sample tracking and enhancing data management within LabConnect's operations.

Clinical Trial Central Laboratory Services Market Report Highlights:

• Based on service, biomarker testing services dominated the market due to genomic and molecular testing advancements. Regulatory agencies are also encouraging biomarker-based drug approvals, further fueling the market expansion
• Based on the phase, Phase III held the largest market share in 2024 due to the high volume of samples and extensive testing requirements. The growing number of late-stage trials and regulatory mandates further drive demand for central lab services
• Based on Indication, frozen held the largest market share in 2024 due to the rising prevalence of cancer and increasing clinical trials for novel therapies. The growing focus on personalized medicine and biomarker-based diagnostics has amplified the demand for specialized laboratory testing
• Based on end use, pharmaceutical & biopharmaceutical companies held the largest market share in 2024 due to their high R&D investments and extensive clinical trial pipelines. The increasing demand for specialized testing, biomarker analysis, and precision medicine further strengthened their reliance on central labs

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Regional Scope
  • 1.1.2. Estimates and Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Purchased Database
  • 1.3.3. GVR's Internal Database
  • 1.3.4. Secondary Sources
  • 1.3.5. Primary Research
• 1.4. Information or Data Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Validation
  • 1.5.1. Region Wise Market: Base Estimates
  • 1.5.2. Global Market: CAGR Calculation
• 1.6. Model Details
  • 1.6.1. Commodity Flow Analysis (Model 1)
  • 1.6.2. Value-Chain-Based Sizing & Forecasting (Model 2)
  • 1.6.3. QFD Model Sizing & Forecasting (Model 3)
  • 1.6.4. Bottom-Up Approach (Model 4)
• 1.7. List of Secondary Sources
• 1.8. List of Abbreviations
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
  • 3.3.2. Market Restraint Analysis
• 3.4. Technological Advancements
  • 3.4.1. Integration of AI and Digital Technologies
• 3.5. Pricing Model Analysis
• 3.6. Clinical Trials Volume Analysis, 2024
  • 3.6.1. Total Number of Clinical Trials, by Region (2024)
  • 3.6.2. Total Number of Clinical Trials, by Phase (2024)
  • 3.6.3. Total Number of Clinical Trials, by Study Design (2024)
  • 3.6.4. Total Number of Clinical Trials, by Key Therapeutic Area (2024)
• 3.7. Industry Analysis Tools
  • 3.7.1. Porter's Five Forces Analysis
  • 3.7.2. PESTEL Analysis
  • 3.7.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Central Laboratory Services Market: Service Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Clinical Trial Central Laboratory Services Market; Service Movement Analysis
• 4.3. Clinical Trial Central Laboratory Services Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
• 4.4. Biomarker Testing Services
  • 4.4.1. Biomarker testing services market estimates and forecasts 2018 - 2030 (USD Million)
• 4.5. Microbiology Services
  • 4.5.1. Microbiology services market estimates and forecasts 2018 - 2030 (USD Million)
• 4.6. Anatomic Pathology/Histology
  • 4.6.1. Anatomic pathology/histology market estimates and forecasts 2018 - 2030 (USD Million)
• 4.7. Pharmacokinetics/Pharmacodynamics (PK/PD)
  • 4.7.1. Pharmacokinetics/Pharmacodynamics (PK/PD) market estimates and forecasts 2018 - 2030 (USD Million)
• 4.8. Genomic and Molecular Testing
  • 4.8.1. Genomic and molecular testing market estimates and forecasts 2018 - 2030 (USD Million)
• 4.9. Sample Collection and Processing
  • 4.9.1. Sample collection and processing market estimates and forecasts 2018 - 2030 (USD Million)
• 4.10. Logistics & Sample Management
  • 4.10.1. Logistics & sample management market estimates and forecasts 2018 - 2030 (USD Million)
• 4.11. Data Management & Reporting
  • 4.11.1. Data management & reporting market estimates and forecasts 2018 - 2030 (USD Million)
• 4.12. Others
  • 4.12.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Clinical Trial Central Laboratory Services Market: Phase Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Clinical Trial Central Laboratory Services Market; Phase Movement Analysis
• 5.3. Clinical Trial Central Laboratory Services Size & Trend Analysis, by Phase, 2018 to 2030 (USD Million)
• 5.4. Phase I
  • 5.4.1. Phase I market estimates and forecasts 2018 - 2030 (USD Million)
• 5.5. Phase II
  • 5.5.1. Phase II market estimates and forecasts 2018 - 2030 (USD Million)
• 5.6. Phase III
  • 5.6.1. Phase III market estimates and forecasts 2018 - 2030 (USD Million)
• 5.7. Phase IV
  • 5.7.1. Phase IV market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Clinical Trial Central Laboratory Services Market: Indication Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Clinical Trial Central Laboratory Services Market; Indication Movement Analysis
• 6.3. Clinical Trial Central Laboratory Services Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
• 6.4. Oncology
  • 6.4.1. Oncology market estimates and forecasts 2018 - 2030 (USD Million)
• 6.5. Cardiology
  • 6.5.1. Cardiology market estimates and forecasts 2018 - 2030 (USD Million)
• 6.6. Neurology
  • 6.6.1. Neurology market estimates and forecasts 2018 - 2030 (USD Million)
• 6.7. Infectious Diseases
  • 6.7.1. Infectious Diseases market estimates and forecasts 2018 - 2030 (USD Million)
• 6.8. Immunology & Autoimmune Diseases
  • 6.8.1. Immunology & autoimmune diseases market estimates and forecasts 2018 - 2030 (USD Million)
• 6.9. Others
  • 6.9.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Clinical Trial Central Laboratory Services Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Clinical Trial Central Laboratory Services Market; End Use Movement Analysis
• 7.3. Clinical Trial Central Laboratory Services Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Pharmaceutical & Biotechnology Companies
  • 7.4.1. Pharmaceutical & Biotechnology Companies market estimates and forecasts 2018 - 2030 (USD Million)
• 7.5. Contract Research Organizations
  • 7.5.1. Contract Research Organizations market estimates and forecasts 2018 - 2030 (USD Million)
• 7.6. Others
  • 7.6.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Clinical Trial Central Laboratory Services Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 8.3. North America
  • 8.3.1. North America clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Mexico clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. Germany clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. UK
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. UK clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Denmark clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. South Korea clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Australia clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Thailand clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Argentina clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Saudi Arabia clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. UAE clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Company Market Position Analysis, 2024
• 9.3. Company Profiles
  • 9.3.1. Labcorp
    • 9.3.1.1. Company overview
    • 9.3.1.2. Financial performance
    • 9.3.1.3. Service benchmarking
    • 9.3.1.4. Strategic initiatives
  • 9.3.2. ICON plc
    • 9.3.2.1. Company overview
    • 9.3.2.2. Financial performance
    • 9.3.2.3. Service benchmarking
    • 9.3.2.4. Strategic initiatives
  • 9.3.3. Eurofins Scientific
    • 9.3.3.1. Company overview
    • 9.3.3.2. Financial performance
    • 9.3.3.3. Service benchmarking
    • 9.3.3.4. Strategic initiatives
  • 9.3.4. Thermo Fisher Scientific Inc.
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Service benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Medpace
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Service benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Q2 Solutions
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Service benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Syneos Health
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Service benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Charles River Laboratories
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Service benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. SGS
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Service benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. LabConnect
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Service benchmarking
    • 9.3.10.4. Strategic initiatives